Crossmark

POLY-Senolytic nanoplatform for tumor-specific eradication of senescent tumor cells and mitigation of radiotherapy-induced immune resistance of cancer

Crossref DOI link: https://doi.org/10.1038/s41467-026-73109-w

Published Online: 2026-06-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lai, Yi https://orcid.org/0009-0007-2673-4618
Zhang, Shunan

Pan, Jiaxing

Lan, Wenyue

Li, Min

Zhu, Zifan

Xu, Leiming

De Geest, Bruno G. https://orcid.org/0000-0001-9826-6170
Lammers, Twan https://orcid.org/0000-0002-1090-6805
Zhang, Wen

Yu, Haijun https://orcid.org/0000-0002-3398-0880
Xu, Zhiai https://orcid.org/0000-0002-4391-2507
License Information

Text and Data Mining valid from 2026-06-18

Accepted Manuscript valid from 2026-06-18
More Information

Article History

Received: 11 January 2025

Accepted: 30 April 2026

First Online: 18 June 2026

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below